Terms: = Lung cancer AND NUTM1, NUT, 256646, ENSG00000184507 AND Diagnosis
51 results:
1. Placental metastasis from maternal nut carcinoma: diagnostic pitfalls and challenges.
Lai JK; Panasci L; Patey NG; Wang H
BMJ Case Rep; 2024 Apr; 17(4):. PubMed ID: 38569728
[TBL] [Abstract] [Full Text] [Related]
2. Neuroendocrine and squamous cell phenotypes of nut carcinoma are potential diagnostic pitfalls that discriminating it from mimickers, such as small cell and squamous cell carcinoma.
Ninomiya H; Sato Y; Inamura K; Dobashi A; Takeuchi K; Mitani H; Mun M; Nishio M; Ishikawa Y
Diagn Pathol; 2024 Feb; 19(1):27. PubMed ID: 38326851
[TBL] [Abstract] [Full Text] [Related]
3. [Primary pulmonary nut carcinoma: a clinicopathological analysis of seven cases].
Zhuang XP; Huang HJ; Chen X; Zheng SL; Li BC; Sun H
Zhonghua Bing Li Xue Za Zhi; 2023 Dec; 52(12):1244-1248. PubMed ID: 38058041
[No Abstract] [Full Text] [Related]
4. Immunodetection of nut Protein: Implementation, Indications, and Results in a Tertiary Reference Center.
Noorwali H; Casiraghi O; Classe M; Adam J; Ngo C; Ghigna MR; Kanaan C; Khneisser P; Bani MA; Cotteret S; Scoazec JY
Appl Immunohistochem Mol Morphol; 2024 Feb; 32(2):64-70. PubMed ID: 37972936
[TBL] [Abstract] [Full Text] [Related]
5. Prolonged Survival of nut Midline Carcinoma and Current Approaches to Treatment.
Kaplan HG; Subramaniam S; Vallières E; Barnett T
Oncologist; 2023 Sep; 28(9):765-770. PubMed ID: 37311046
[TBL] [Abstract] [Full Text] [Related]
6. Clinical and molecular features of pulmonary nut carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.
Chen M; Chen X; Zhang Y; Wang W; Jiang L
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6361-6370. PubMed ID: 36752907
[TBL] [Abstract] [Full Text] [Related]
7. diagnosis, Treatment and Prognosis of Primary Pulmonary nut Carcinoma: A Literature Review.
Yuan J; Xu Z; Guo Y
Curr Oncol; 2022 Sep; 29(10):6807-6815. PubMed ID: 36290813
[TBL] [Abstract] [Full Text] [Related]
8. SMARCA4-deficient undifferentiated tumor that responded to chemotherapy in combination with immune checkpoint inhibitors: A case report.
Utsumi T; Taniguchi Y; Noda Y; Fukai M; Kibata K; Murakawa T
Thorac Cancer; 2022 Aug; 13(15):2264-2266. PubMed ID: 35778998
[TBL] [Abstract] [Full Text] [Related]
9. nut Carcinoma: A Clinical, Morphological and Immunohistochemical Mimicker-The Role of RNA Sequencing in the Diagnostic Procedure.
Gasljevic G; Matter MS; Blatnik O; Unk M; Dirnhofer S
Int J Surg Pathol; 2022 May; 30(3):273-277. PubMed ID: 34738485
[No Abstract] [Full Text] [Related]
10. BRD3-nutm1-expressing nut carcinoma of lung on endobronchial ultrasound-guided transbronchial needle aspiration cytology, a diagnostic pitfall.
Aryal SC; Zia S; Rodgers S; Shen Y; Perry K; Yuan L
Diagn Cytopathol; 2022 Feb; 50(2):E47-E53. PubMed ID: 34672128
[TBL] [Abstract] [Full Text] [Related]
11. Unusual lung tumors-from morphology to genetics.
Boland JM
Mod Pathol; 2022 Jan; 35(Suppl 1):57-65. PubMed ID: 34518633
[TBL] [Abstract] [Full Text] [Related]
12. Clinicopathological and molecular characterizations of pulmonary nut midline carcinoma.
Xie M; Fu X; Wang W
Cancer Med; 2021 Sep; 10(17):5757-5764. PubMed ID: 34409758
[TBL] [Abstract] [Full Text] [Related]
13. Misleading Germ Cell Phenotype in Pulmonary nut Carcinoma Harboring the ZNF532-nutm1 Fusion.
Agaimy A; Haller F; Renner A; Niedermeyer J; Hartmann A; French CA
Am J Surg Pathol; 2022 Feb; 46(2):281-288. PubMed ID: 34232599
[TBL] [Abstract] [Full Text] [Related]
14. nut carcinoma of the lung.
Lantuejoul S; Pissaloux D; Ferretti GR; McLeer A
Semin Diagn Pathol; 2021 Sep; 38(5):72-82. PubMed ID: 34176698
[TBL] [Abstract] [Full Text] [Related]
15. Thoracic nut carcinoma: Common pathological features despite diversity of clinical presentations.
Fekkar A; Emprou C; Lefebvre C; Ferretti G; Stephanov O; Pissaloux D; Mc Leer A; Toffart AC; Rousseaux S; Khochbin S; Lantuejoul S; Valmary-Degano S
Lung Cancer; 2021 Aug; 158():55-59. PubMed ID: 34119933
[TBL] [Abstract] [Full Text] [Related]
16. Challenging diagnosis in nut Carcinoma.
Claudia G; Alexandra G
Int J Surg Pathol; 2021 Oct; 29(7):722-725. PubMed ID: 34106022
[TBL] [Abstract] [Full Text] [Related]
17. Updates in the molecular pathology of non-small cell lung cancer.
Paver E; O'Toole S; Cheng XM; Mahar A; Cooper WA
Semin Diagn Pathol; 2021 Sep; 38(5):54-61. PubMed ID: 33985831
[TBL] [Abstract] [Full Text] [Related]
18. nut Midline Carcinoma of the lung: Computed Tomography Findings in 10 Patients.
Chang AI; Kim TS; Han J; Kim TJ; Choi JY
J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):330-336. PubMed ID: 33661151
[TBL] [Abstract] [Full Text] [Related]
19. Update on genetically defined lung neoplasms: nut carcinoma and thoracic SMARCA4-deficient undifferentiated tumors.
Chatzopoulos K; Boland JM
Virchows Arch; 2021 Jan; 478(1):21-30. PubMed ID: 33409598
[TBL] [Abstract] [Full Text] [Related]
20. P63-negative pulmonary nut carcinoma arising in the elderly: a case report.
Numakura S; Saito K; Motoi N; Mori T; Saito Y; Yokote F; Kanamoto Y; Asami M; Sakai T; Yamauchi Y; Sakao Y; Uozaki H; Kawamura M
Diagn Pathol; 2020 Nov; 15(1):134. PubMed ID: 33176817
[TBL] [Abstract] [Full Text] [Related]
[Next]
